Author

P. L. Choyke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:imaging· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. N. Alilin· 1 shared A. Ton· 1 shared B. Capaldo· 1 shared B. M. Warner· 1 shared B. Turkbey· 1 shared C. Bastian· 1 shared C. Olkowski· 1 shared C. Schultz· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. N. Alilin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancer

F. Ahmad, M. White, K. Yamamoto, D. R. Crooks, S. Agarwal, Y. Yang, B. Capaldo, S. Raj, A. N. Alilin, A. Ton, S. Adler, J. Seidel, C. Olkowski, M. K. Cherukuri, P. L. Choyke, , J. R. Brender

This study investigates metabolic and imaging phenotypes in prostate cancer linked to RB1 and TP53 loss, finding metabolic changes that may inform multimodal imaging strategies.

bioRxiv · Nov 15, 2023Cancer Biology

MRI Guided Fresh Tissue Procurement in Radical Prostatectomy Specimens: An Evolutionary Paradigm

R. Z. Freidlin, J. Krynitsky, C. Bastian, C. Schultz, J. Custer, S. Young, S. Mehralivand, M. J. Merino, V. A. Valera, P. Pinto, B. Turkbey, P. L. Choyke, T. J. Pohida, M. A. Garmendia

This paper evaluates new methods for precise fresh tissue sampling in prostate specimens using 3D-printed molds, showing improved accuracy over traditional surgical estimation.

bioRxiv · May 9, 2022 · PreprintBioengineering

ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma

O. J. Kelada, N. T. Gutsche, M. Bell, R. M. Berman, K. E. Baidoo, B. M. Warner, L. P. Szajek, J. Hong, M. Ho, P. L. Choyke, F. E. Escorcia

This paper demonstrates that the immunoPET agent [89Zr]Zr-DFO-TAB-H14 specifically and stoichiometrically binds to GPC3 in human liver cancer models, serving as a potential in vivo sensor for HCC diagnosis and therapy selection.

bioRxiv · Jan 31, 2020Cancer Biology